Organovo Holdings (Seite 77)
eröffnet am 23.10.12 18:24:31 von
neuester Beitrag 11.05.22 09:20:03 von
neuester Beitrag 11.05.22 09:20:03 von
Beiträge: 1.673
ID: 1.177.413
ID: 1.177.413
Aufrufe heute: 0
Gesamt: 314.203
Gesamt: 314.203
Aktive User: 0
ISIN: US68620A2033 · WKN: A2QA6Q · Symbol: 4OR1
1,0480
EUR
-4,73 %
-0,0520 EUR
Letzter Kurs 19.04.24 Tradegate
Neuigkeiten
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 3.000,00 | +74.900,00 | |
| 3,5000 | +30,60 | |
| 1,1060 | +30,10 | |
| 1,5400 | +25,71 | |
| 7,0700 | +16,86 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,3500 | -15,63 | |
| 19,700 | -16,53 | |
| 0,8700 | -20,18 | |
| 4,6600 | -28,75 | |
| 0,6021 | -35,26 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 51.303.258 von PhaseDrei am 14.12.15 19:16:50Was sagt das genau aus?
Du meinst wenn die Shortis alle abgebaut sind gehts dann aufwährts?
Du meinst wenn die Shortis alle abgebaut sind gehts dann aufwährts?
Antwort auf Beitrag Nr.: 51.250.416 von PhaseDrei am 06.12.15 12:09:36Hallo,
und wieder ca. 850 000 weniger. Schritt für Schritt - 5x in Folge. Seit dem 15.09.15 bereits um über
7 Mio reduziert
Dies ist der niedrigste Stand seit einem Jahr!
Avg Daily Share Volume Days To Cover
11/30/2015 15,883,713 736,937 21.553692
11/13/2015 16,746,164 683,235 24.510109
10/30/2015 17,293,371 854,454 20.239090
10/15/2015 17,817,881 1,253,311 14.216648
9/30/2015 18,567,666 2,026,720 9.161436
9/15/2015 23,048,702 1,019,797
Read more: http://www.nasdaq.com/symbol/onvo/short-interest#ixzz3uJt9Ye…
Gruß, Phase
und wieder ca. 850 000 weniger. Schritt für Schritt - 5x in Folge. Seit dem 15.09.15 bereits um über
7 Mio reduziert
Dies ist der niedrigste Stand seit einem Jahr!
Avg Daily Share Volume Days To Cover
11/30/2015 15,883,713 736,937 21.553692
11/13/2015 16,746,164 683,235 24.510109
10/30/2015 17,293,371 854,454 20.239090
10/15/2015 17,817,881 1,253,311 14.216648
9/30/2015 18,567,666 2,026,720 9.161436
9/15/2015 23,048,702 1,019,797
Read more: http://www.nasdaq.com/symbol/onvo/short-interest#ixzz3uJt9Ye…
Gruß, Phase
Antwort auf Beitrag Nr.: 51.216.693 von Schaeffi am 01.12.15 19:53:35Hallo,
drei weitere Stellenausschreibungen - insgesamt 16!
LOCATION DATE POSTED
Research Associate - KR
US-CA-San Diego 12/5/2015 >
Senior Director of Global Marketing
US-CA-San Diego 12/5/2015 >
Research Associate - Kidney
US-CA-San Diego
Übrigens:
allen, die ernsthaft an einer Langfristanlage (> 3 Jahre) in ONVO interessiert sind, sei der ca. 30 minütige Podcast der PJ-Healthcare- Konferenz vom 2.12 wärmstens empfohlen.
http://edge.media-server.com/m/p/3qzqquge
Gruß, Phase
drei weitere Stellenausschreibungen - insgesamt 16!
LOCATION DATE POSTED
Research Associate - KR
US-CA-San Diego 12/5/2015 >
Senior Director of Global Marketing
US-CA-San Diego 12/5/2015 >
Research Associate - Kidney
US-CA-San Diego
Übrigens:
allen, die ernsthaft an einer Langfristanlage (> 3 Jahre) in ONVO interessiert sind, sei der ca. 30 minütige Podcast der PJ-Healthcare- Konferenz vom 2.12 wärmstens empfohlen.
http://edge.media-server.com/m/p/3qzqquge
Gruß, Phase
Organovo to Present at 2015 Piper Jaffray Healthcare Conference
Wednesday, December 2, 2015 at 11:00am Eastern Time (ET). New York City.Organovo Holdings, Inc. (NYSE MKT:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced that Chairman and Chief Executive Officer Keith Murphy is scheduled to speak at the 2015 Piper Jaffray Healthcare Conference in New York City on Wednesday, December 2, 2015 at 11:00am Eastern Time (ET). The presentation will be simultaneously audio webcast at http://www.organovo.com. The audio webcast will be archived for 90 days following the conference.
Antwort auf Beitrag Nr.: 51.103.200 von PhaseDrei am 16.11.15 19:45:54Hallo,
...und wieder ca. 550 K weniger
11/13/2015 16,746,164 683,235 24.510109
10/30/2015 17,293,371 854,454 20.239090
10/15/2015 17,817,881 1,253,311
Read more: http://www.nasdaq.com/symbol/onvo/short-interest#ixzz3siZZLE…
Gruß, Phase
...und wieder ca. 550 K weniger
11/13/2015 16,746,164 683,235 24.510109
10/30/2015 17,293,371 854,454 20.239090
10/15/2015 17,817,881 1,253,311
Read more: http://www.nasdaq.com/symbol/onvo/short-interest#ixzz3siZZLE…
Gruß, Phase
Trading Spotlight
Antwort auf Beitrag Nr.: 51.075.285 von geldspender am 12.11.15 18:46:41Hallo,
die Zahlen des 2. Quartals (des Geschäftsjahres, dass bei ONVO bekanntlich am 31.03.2016 endet)
lagen aus meiner Sicht, im Rahmen:
geringe Umsätze - exvive 3D braucht seine Zeit- dafür erwartungsgemäß steigende Ausgaben im Zuge der massiven Expansion;
die Umsatzzahlen für den Lebertest werden auch in den kommenden 2 Quartalen nicht sonderlich ansteigen;
das lässt sich anhand der getätigten Aussagen leicht berechnen;
Positiv sicher die deutlich schnellere Entwicklung des Nierentests, die funktionelle Validierung bereit im Oktober statt wie angekündigt im Dez. abgeschlossen - gut so
das lässt auf eine frühere Marktfreigabe im 3. Quartal des Kalenderjahres hoffen! Bislang wurde stets September genannt!
übrigens:
short interest geht weiter zurück:
10/30/2015 17,293,371 854,454 20.239090
10/15/2015 17,817,881 1,253,311 14.216648
9/30/2015 18,567,666 2,026,720 9.161436
und die Instis nehmen kontinuierlich zu
Institutional Ownership
30.81%
Total Institutional Shares
135 28,469,925
Fazit:
alles im grünen Bereich - aber alles braucht seine Zeit -
Geduld ist gefragt- wer mit letzterer Probleme hat, sollte besser die Finger von Organovo lassen
Gruß, Phase
die Zahlen des 2. Quartals (des Geschäftsjahres, dass bei ONVO bekanntlich am 31.03.2016 endet)
lagen aus meiner Sicht, im Rahmen:
geringe Umsätze - exvive 3D braucht seine Zeit- dafür erwartungsgemäß steigende Ausgaben im Zuge der massiven Expansion;
die Umsatzzahlen für den Lebertest werden auch in den kommenden 2 Quartalen nicht sonderlich ansteigen;
das lässt sich anhand der getätigten Aussagen leicht berechnen;
Positiv sicher die deutlich schnellere Entwicklung des Nierentests, die funktionelle Validierung bereit im Oktober statt wie angekündigt im Dez. abgeschlossen - gut so
das lässt auf eine frühere Marktfreigabe im 3. Quartal des Kalenderjahres hoffen! Bislang wurde stets September genannt!
übrigens:
short interest geht weiter zurück:
10/30/2015 17,293,371 854,454 20.239090
10/15/2015 17,817,881 1,253,311 14.216648
9/30/2015 18,567,666 2,026,720 9.161436
und die Instis nehmen kontinuierlich zu
Institutional Ownership
30.81%
Total Institutional Shares
135 28,469,925
Fazit:
alles im grünen Bereich - aber alles braucht seine Zeit -
Geduld ist gefragt- wer mit letzterer Probleme hat, sollte besser die Finger von Organovo lassen
Gruß, Phase
Ich werde diese Aktie beobachten, mal sehen wo der Kurs hin geht.
Antwort auf Beitrag Nr.: 50.997.777 von PhaseDrei am 03.11.15 19:57:11Hallo,
Und wieder eien neue und bedeutende Stellenausschreibung:
JOB DESCRIPTION
Senior Director Global Marketing
Organovo has commercial products on the market & additional products in discovery & development. Our products & technology have already attracted an excellent business team & we are currently experiencing phenomenal growth with this Leading Edge Technology!
We currently have an opening for a Senior Director of Global Marketing efforts. With our phenomenal growth, we are in the process of swift commercialization and expansion of our business. Our goal is to identify & present our products & services to potential customers, partners & collaborators on a global scale.
Senior Director of Global Marketing Responsibilities:
The successful candidate will be responsible for developing and establishing innovative marketing strategies to support the companies’ commercial objectives, driving day-to-day marketing effectiveness.
The successful candidate will be a key member of leadership team and will participate in leadership meetings and in strategic planning, including setting objectives and strategies as well as taking accountability for implementation and results.
Create, develop and implement a global comprehensive tactical and strategic marketing plan that centers on promoting the Organovo’s products & services.
Drive revenue growth and market expansion via execution of an effective marketing plan and provision of support to sales and marketing teams globally.
The global leader will maintain an in depth knowledge of the market landscape, including working with R&D & other cross functional teams to develop product/service forecasts for new offerings and position offerings for market success.
Manage the global marketing team, and develop key company messaging and positioning to be conveyed through marketing campaigns.
Senior Director of Global Marketing Skills & Experience:
A PhD within Life Sciences, with essential knowledge of the Cell Biology highly preferred.
The successful candidate will have at least 10 plus years of experience marketing Life Science products or services in a commercial product development setting with an extensive external network in the scientific community.
Experience in toxicology or drug discovery is a plus.
Experience creating and implementing tactical marketing plans, with previous global management experience successfully leading cross-functional teams in marketing, and product management.
Experience & professionalism that has resulted in a network of industry colleagues, KOL’s & potential customers.
Excellent leadership and communication skills. The position offers the opportunity to become an integral part of a Life Science management team with responsibility for rapidly growing a business.
Experience successfully managing Directors of high level individual contributors.
Ability to identify key data sources and utilize data driven insights to effectively improve business decisions.
Experience designing and executing research projects to identify consumer habits and practices, satisfaction levels, product concept development, usage and awareness, purchase drivers, and branding and positioning.
Ability to interface with high levels of internal management, advertising agencies, marketing, strategic planning, and marketing research suppliers/consultants.
Strong analytical & critical thinking skills.
Ability to operate well both strategically & tactically.
Experience with forecasting of resources & budgets.
Experience with start ups or launching novel products & services and developing markets a big plus.
DISCLAIMER: The above statements are intended to describe the general nature and level of work being performed by incumbents assigned to this job. This is not intended to be an exhaustive list of all the functions, responsibilities, duties and skills required for the position, and Organovo retains the discretion to modify functions, responsibilities, duties and skills at any time, including modifying the time devoted to such activities, deleting activities, and assigning other activities.
Organovo is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, sex, color, religion, sexual orientation, gender identity, national origin, protected veteran status, or on the basis of disability.
If you are an individual with a disability and require a reasonable accommodation to complete any part of the application process, or are limited in the ability or unable to access or use this online application process and need an alternative method for applying, you may contact us at 858-224-1057 for assistance. #CB
Gruß, Phase
Und wieder eien neue und bedeutende Stellenausschreibung:
JOB DESCRIPTION
Senior Director Global Marketing
Organovo has commercial products on the market & additional products in discovery & development. Our products & technology have already attracted an excellent business team & we are currently experiencing phenomenal growth with this Leading Edge Technology!
We currently have an opening for a Senior Director of Global Marketing efforts. With our phenomenal growth, we are in the process of swift commercialization and expansion of our business. Our goal is to identify & present our products & services to potential customers, partners & collaborators on a global scale.
Senior Director of Global Marketing Responsibilities:
The successful candidate will be responsible for developing and establishing innovative marketing strategies to support the companies’ commercial objectives, driving day-to-day marketing effectiveness.
The successful candidate will be a key member of leadership team and will participate in leadership meetings and in strategic planning, including setting objectives and strategies as well as taking accountability for implementation and results.
Create, develop and implement a global comprehensive tactical and strategic marketing plan that centers on promoting the Organovo’s products & services.
Drive revenue growth and market expansion via execution of an effective marketing plan and provision of support to sales and marketing teams globally.
The global leader will maintain an in depth knowledge of the market landscape, including working with R&D & other cross functional teams to develop product/service forecasts for new offerings and position offerings for market success.
Manage the global marketing team, and develop key company messaging and positioning to be conveyed through marketing campaigns.
Senior Director of Global Marketing Skills & Experience:
A PhD within Life Sciences, with essential knowledge of the Cell Biology highly preferred.
The successful candidate will have at least 10 plus years of experience marketing Life Science products or services in a commercial product development setting with an extensive external network in the scientific community.
Experience in toxicology or drug discovery is a plus.
Experience creating and implementing tactical marketing plans, with previous global management experience successfully leading cross-functional teams in marketing, and product management.
Experience & professionalism that has resulted in a network of industry colleagues, KOL’s & potential customers.
Excellent leadership and communication skills. The position offers the opportunity to become an integral part of a Life Science management team with responsibility for rapidly growing a business.
Experience successfully managing Directors of high level individual contributors.
Ability to identify key data sources and utilize data driven insights to effectively improve business decisions.
Experience designing and executing research projects to identify consumer habits and practices, satisfaction levels, product concept development, usage and awareness, purchase drivers, and branding and positioning.
Ability to interface with high levels of internal management, advertising agencies, marketing, strategic planning, and marketing research suppliers/consultants.
Strong analytical & critical thinking skills.
Ability to operate well both strategically & tactically.
Experience with forecasting of resources & budgets.
Experience with start ups or launching novel products & services and developing markets a big plus.
DISCLAIMER: The above statements are intended to describe the general nature and level of work being performed by incumbents assigned to this job. This is not intended to be an exhaustive list of all the functions, responsibilities, duties and skills required for the position, and Organovo retains the discretion to modify functions, responsibilities, duties and skills at any time, including modifying the time devoted to such activities, deleting activities, and assigning other activities.
Organovo is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, sex, color, religion, sexual orientation, gender identity, national origin, protected veteran status, or on the basis of disability.
If you are an individual with a disability and require a reasonable accommodation to complete any part of the application process, or are limited in the ability or unable to access or use this online application process and need an alternative method for applying, you may contact us at 858-224-1057 for assistance. #CB
Gruß, Phase
Antwort auf Beitrag Nr.: 50.964.705 von PhaseDrei am 29.10.15 20:24:34Hallo,
exVive3D Kidney Tissue Development
Functional validation – C4Q15
Na? Wann kommen die ersehnten News zum Nierentest?
In Anbetracht der Tatsache dass K M bislang alle timeframes nicht nur eingehalten sondern stets sogar übererfüllt hat, ist fast täglich mit einer News zu rechnen;
Vielleicht noch vor dem CC am 9.11 ?
Und wie entwickelt sich der Kurs? steigt ONVO in den kommenden Handelstagen weiter, um nach den sicher weiterhin noch verhaltenen Zahlen, die am 9.11. verkündet werden wieder mal abverkauft zu werden oder aber
gibt es doch eine Überraschung und einen völlig unerwarteten Kursverlauf?
Sicherlich Fragen, die so manchen Trader beschäftigen!
Mich allerdings weniger - Die derzeitige Kursentwicklung ist für mich als Langfristanleger derzeit zweitrangig - noch - andere Punkte das Unternehmen betreffend sind aus meiner Sicht zur Zeit interessanter;
Übrigens:
mein ONVO-Depot befindet sich - wie das gesamte Unternehmen- weiterhin in der Ausbau-Phase
Gruß, Phase
exVive3D Kidney Tissue Development
Functional validation – C4Q15
Na? Wann kommen die ersehnten News zum Nierentest?
In Anbetracht der Tatsache dass K M bislang alle timeframes nicht nur eingehalten sondern stets sogar übererfüllt hat, ist fast täglich mit einer News zu rechnen;
Vielleicht noch vor dem CC am 9.11 ?
Und wie entwickelt sich der Kurs? steigt ONVO in den kommenden Handelstagen weiter, um nach den sicher weiterhin noch verhaltenen Zahlen, die am 9.11. verkündet werden wieder mal abverkauft zu werden oder aber
gibt es doch eine Überraschung und einen völlig unerwarteten Kursverlauf?
Sicherlich Fragen, die so manchen Trader beschäftigen!
Mich allerdings weniger - Die derzeitige Kursentwicklung ist für mich als Langfristanleger derzeit zweitrangig - noch - andere Punkte das Unternehmen betreffend sind aus meiner Sicht zur Zeit interessanter;
Übrigens:
mein ONVO-Depot befindet sich - wie das gesamte Unternehmen- weiterhin in der Ausbau-Phase
Gruß, Phase
Durchsuchen
